Status:

COMPLETED

rTMS Effects on Smoking Cessation and Cognition in Schizophrenia

Lead Sponsor:

Centre for Addiction and Mental Health

Conditions:

Cigarette Smoking

Schizophrenia

Eligibility:

All Genders

18-60 years

Phase:

NA

Brief Summary

Patients with schizophrenia have high rates of cigarette smoking and tobacco dependence, and great difficulties in quitting smoking. The development of novel and more effective treatments for tobacco ...

Eligibility Criteria

Inclusion

  • DSM-IV diagnosis of schizophrenia or schizoaffective disorder
  • Smoking at least 10 cigarettes per day and a Fagerstrom score of at least 4.
  • Willing to quit smoking in the next 30 days.

Exclusion

  • Active alcohol or illicit drug abuse or dependence in the past 3 months
  • A history of seizures, head trauma or space occupying lesions.
  • A history of alcohol or illicit drug abuse in the past 6 months.
  • Intolerance of the nicotine patch or its excipients
  • Evidence for psychiatric instability as judged by acute psychotic exacerbations, suicidal or homicidal ideation.
  • Females who are pregnant.

Key Trial Info

Start Date :

December 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2011

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT00736710

Start Date

December 1 2008

End Date

May 1 2011

Last Update

December 5 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Centre for Addiction and Mental Health

Toronto, Ontario, Canada, M5S 2S1